Clinical Outcomes of Decitabine and the Role of WT-1 Expression as a Surrogate Prognostic Marker for Patients with Elderly Acute Myeloid Leukemia

被引：1
|
作者：
Cho, Byung-Sik [1 ]
Shin, Seung-Hwan [2 ]
Lee, Sung-Eun [1 ]
Park, Sung-Soo [1 ]
Yoon, Jae-Ho [1 ]
Yahng, Seung-Ah [1 ]
Kim, Hee-je [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol,Leukemia Res Inst, Seoul, South Korea
[2] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
elderly acute myeloid leukemia; decitabine; WT1;
D O I：
10.1016/j.clml.2018.07.049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-123
引用
收藏
页码：S200 / S201
页数：2
相关论文
共 50 条
  • [31] Assessment of WT1 expression as a marker of treatment outcome in karyotype normal acute myeloid leukemia patients in Pakistan
    Ahmed, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S59 - S59
  • [32] Outcomes and charges of elderly patients with acute myeloid leukemia
    Katz, Laura M.
    Howell, Jamie B.
    Doyle, John J.
    Stern, Lee S.
    Rosenblatt, Lisa C.
    Piech, Catherine Tak
    Zilberberg, Marya D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (11) : 850 - 857
  • [33] PROGNOSTIC SIGNIFICANCE OF WT1 EXPRESSION AT DIAGNOSIS AND END OF INDUCTION IN EGYPTIAN ADULT ACUTE MYELOID LEUKEMIA PATIENTS
    Mossallam, I.
    Hamid, M. Abdel
    Mahmoud, K.
    HAEMATOLOGICA, 2012, 97 : 505 - 506
  • [34] Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia
    Barragán, E
    Cervera, J
    Bolufer, P
    Ballester, S
    Martín, G
    Fernández, P
    Collado, R
    Sayas, MJ
    Sanz, MA
    HAEMATOLOGICA, 2004, 89 (08) : 926 - 933
  • [35] Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients
    Mossallam, Ghada I.
    Hamid, Thoraya M. Abdel
    Mahmoud, Hossam K.
    HEMATOLOGY, 2013, 18 (02) : 69 - 73
  • [36] WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy
    Mehralizadeh, Hossein
    Aliparasti, Mohammad Reza
    Talebi, Mehdi
    Salekzamani, Shabnam
    Almasi, Shohreh
    Raeisis, Morteza
    Yousefi, Mehdi
    Movassaghpour, AliAkbar
    ADVANCED PHARMACEUTICAL BULLETIN, 2021, 11 (01) : 197 - 203
  • [37] Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
    Kim, Mihee
    Ahn, Seo-Yeon
    Kim, TaeHyung
    Jung, Sung-Hoon
    Song, Ga-Young
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Mi Yeon
    Park, Ju Heon
    Shin, Myung-Geun
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    HEMATOLOGY, 2024, 29 (01)
  • [38] Prognostic Analysis According to European Leukemianet 2022 Risk Stratification for Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine
    Kim, Mihee
    Kim, Taehyung Simon
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Song, Ga-Young
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seunghyun
    Kim, MiYeon
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Kim, Dennis
    BLOOD, 2022, 140 : 6094 - 6095
  • [39] PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    JOHNSON, PRE
    YIN, JAL
    LEUKEMIA & LYMPHOMA, 1994, 16 (1-2) : 51 - 56
  • [40] Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia
    Plesa, Claudilu
    Chelghoum, Youcef
    Plesa, Adriana
    Elhamri, Mohamed
    Tigaud, Isabelle
    Michallet, Mauricette
    Dumontet, Charles
    Thomas, Xavier
    CANCER, 2008, 112 (03) : 572 - 580
12345